Articles From: Safeway Federal Credit Union and Spokane City Credit Union Select D+H for Integrated Core Processing and Self-Service Solutions to Sagent Pharmaceuticals Reports Second Quarter 2014 Financial Results


2014/11/10
Industry-leading Solutions Help Credit Unions Provide Seamless Member Experience across Channels LAKE MARY, FL , Nov.
Sign-up for Safeway Federal Credit Union and Spokane City Credit Union Select D+H for Integrated Core Processing and Self-Service Solutions investment picks
http://media.marketwire.com/attachments/201304/144900_SafewayforImmediateReleaseLogo.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146156&ProfileId=051205&sourceType=1 PLEASANTON, CA --
Sign-up for Safeway Inc. Announces Consent Solicitation for $680 Million Principal Amount of Outstanding Senior Notes Due 2016, 2017 and 2019 investment picks
http://media.marketwire.com/attachments/201102/33469_SWY_R_HRZ_CLR.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149337&ProfileId=051205&sourceType=1 PLEASANTON, CA --
Sign-up for Safeway Inc. Announces Receipt of Requisite Consents for Its Senior Notes Due 2016 and Extension of Its Consent Solicitation for Its Senior Notes Due 2017 With an Increased Consent Fee investment picks
PLEASANTON, Calif.
Sign-up for Safeway Inc. Announces Receipt of Requisite Consents for its Senior Notes Due 2017 investment picks
http://media.marketwire.com/attachments/201304/144900_SafewayforImmediateReleaseLogo.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1139583&ProfileId=051205&sourceType=1 PLEASANTON, CA --
Sign-up for Safeway Inc. Board of Directors Declares Quarterly Dividend investment picks
By Michael Calia Safeway Inc., which is on the verge of completing its merger with rival Albertsons, said its revenue for the most recent period increased slightly, as the supermarket operator expressed belief in a modest rebound in consumer confidence.
Sign-up for Safeway sales rise as Albertsons merger nears investment picks
2014/11/6
Safeway to Launch AIR MILES Cash Instant Redemption Feature Canada NewsWire Beginning November 14 , AIR MILES Collectors Can Redeem Reward Miles for In-Store Purchases TORONTO , Nov.
Sign-up for Safeway to Launch AIR MILES Cash Instant Redemption Feature investment picks
2014/10/23
Robert Wall French aerospace supplier Safran SA said Thursday its third-quarter revenue rose 6.8% amid sustained demand for engines powering Boeing Co.
Sign-up for Safran Revenue Rises on Sustained Demand for Jet Engines investment picks
2014/10/13
GROSSE POINTE FARMS, Mich.
Sign-up for Saga Communications, Inc. Announces Date and Time of 3rd Quarter 2014 Earnings Release and Conference Call investment picks
2014/9/23
GROSSE POINTE FARMS, Mich.
Sign-up for Saga Communications, Inc. Declares Quarterly Cash Dividend of $0.20 per Share investment picks
2014/11/7
Net Operating Revenue Increased 4.4% GROSSE POINTE FARMS, Mich.
Sign-up for Saga Communications, Inc. Reports 3rd Quarter Results investment picks
2014/11/10
Hundreds of UK Businesses Abandon Sage in Favour of NetSuite Cloud to Drive Business Growth DWA Among the Hundreds of Companies That Has Already Reached the End of the Line with Sage LONDON , Nov.
Sign-up for Sage Lines Terminate At NetSuite investment picks
CAMBRIDGE, Mass., Sept.
Sign-up for SAGE Therapeutics Appoints Michael F. Cola to the Company's Board of Directors investment picks
CAMBRIDGE, Mass., Oct.
Sign-up for SAGE Therapeutics Initiates Exploratory Study of SAGE-547 in Essential Tremor investment picks
SAGE Therapeutics (NASDAQ: SAGE) today presented preclinical data on its second-generation neuroactive steroid, SAGE-217, at the Twelfth Eilat Conference on New Anti-Epileptic Drugs in Madrid, Spain.
Sign-up for SAGE Therapeutics Presents New Preclinical Data on SAGE-217 at Eilat Conference on New Anti-Epileptic Drugs investment picks
SAGE-547 Met Primary and Secondary Efficacy and Safety Endpoint Targets CAMBRIDGE, Mass., Nov.
Sign-up for SAGE Therapeutics Reports Positive Top-Line Phase 2 Data of SAGE-547 in Patients With Super-Refractory Status Epilepticus investment picks
SAGE Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today provided business updates and reported financial results for the quarter ended June 30, 2014.
Sign-up for SAGE Therapeutics Reports Second Quarter 2014 Financial Results investment picks
CAMBRIDGE, Mass., Sept.
Sign-up for SAGE Therapeutics to Participate in the 2014 Leerink Partners Rare Disease Roundtable investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for SAGE to Present at Credit Suisse 23rd Annual Healthcare Conference investment picks
Expands Sagent's Global Footprint, Product Portfolio and Industry Leading Development Pipeline SCHAUMBURG, Ill., Oct.
Sign-up for Sagent Pharmaceuticals Announces Acquisition of Omega Laboratories investment picks
SCHAUMBURG, Ill., Sept.
Sign-up for Sagent Pharmaceuticals Announces the Introduction of Oxaliplatin Injection, USP investment picks
SCHAUMBURG, Ill., Sept.
Sign-up for Sagent Pharmaceuticals Announces the Launch of GLYDO(TM) (Lidocaine HCI Jelly USP, 2%) investment picks
SCHAUMBURG, Ill., Sept.
Sign-up for Sagent Pharmaceuticals Announces the Launch of Ibandronate Sodium Injection investment picks
SCHAUMBURG, Ill., Sept.
Sign-up for Sagent Pharmaceuticals Announces the Launch of Ketorolac Tromethamine Injection, USP investment picks
SCHAUMBURG, Ill., Aug.
Sign-up for Sagent Pharmaceuticals Announces the Reintroduction of Irinotecan Hydrochloride Injection, USP investment picks
SCHAUMBURG, Ill., July 30, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) , a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced financial results for the quarter ended June 30, 2014.
Sign-up for Sagent Pharmaceuticals Reports Second Quarter 2014 Financial Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Safeway Federal Credit Union and Spokane City Credit Union Select D+H for Integrated Core Processing and Self-Service Solutions to Sagent Pharmaceuticals Reports Second Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent